Sage Therapeutics Stock Forecast - Naive Prediction

SAGEDelisted Stock  USD 8.68  0.00  0.00%   
The Naive Prediction forecasted value of Sage Therapeutics on the next trading day is expected to be 9.29 with a mean absolute deviation of 0.28 and the sum of the absolute errors of 17.11. Sage Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Sage Therapeutics stock prices and determine the direction of Sage Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Sage Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
A naive forecasting model for Sage Therapeutics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Sage Therapeutics value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Sage Therapeutics Naive Prediction Price Forecast For the 12th of December 2025

Given 90 days horizon, the Naive Prediction forecasted value of Sage Therapeutics on the next trading day is expected to be 9.29 with a mean absolute deviation of 0.28, mean absolute percentage error of 0.15, and the sum of the absolute errors of 17.11.
Please note that although there have been many attempts to predict Sage Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sage Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Sage Therapeutics Stock Forecast Pattern

Backtest Sage TherapeuticsSage Therapeutics Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Sage Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Sage Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria116.2447
BiasArithmetic mean of the errors None
MADMean absolute deviation0.2805
MAPEMean absolute percentage error0.0356
SAESum of the absolute errors17.1101
This model is not at all useful as a medium-long range forecasting tool of Sage Therapeutics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Sage Therapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Sage Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sage Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
8.688.688.68
Details
Intrinsic
Valuation
LowRealHigh
7.027.029.55
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Sage Therapeutics. Your research has to be compared to or analyzed against Sage Therapeutics' peers to derive any actionable benefits. When done correctly, Sage Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Sage Therapeutics.

Sage Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sage Therapeutics stock to make a market-neutral strategy. Peer analysis of Sage Therapeutics could also be used in its relative valuation, which is a method of valuing Sage Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Sage Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Sage Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sage Therapeutics shares will generate the highest return on investment. By undertsting and applying Sage Therapeutics stock market strength indicators, traders can identify Sage Therapeutics entry and exit signals to maximize returns.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Consideration for investing in Sage Stock

If you are still planning to invest in Sage Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sage Therapeutics' history and understand the potential risks before investing.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data